Munich is one of Europe’s leading biotech locations with a strategic focus on the development of personalized medicine. The 5th Munich Biomarker Conference is organized by BioM and the internationally well connected Munich Biotech Cluster community. Though we bring together international experts from biotech and pharma industry with scientists and physicians. The programme covers all stages of biomarker development, from basic research to personalized treatment of patients. A focus lies on the translation of academic research findings into industry-driven drug development. A second core topic is the realization of individualized treatment in the standard of care. Measures of process development, companion diagnostics, precondition in regulatory and collaboration frameworks and financing or reimbursement will be discussed.